{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T06:45:50Z","timestamp":1773038750318,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2009,11,13]],"date-time":"2009-11-13T00:00:00Z","timestamp":1258070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1038\/eye.2009.271","type":"journal-article","created":{"date-parts":[[2009,11,13]],"date-time":"2009-11-13T10:42:53Z","timestamp":1258108973000},"page":"994-998","source":"Crossref","is-referenced-by-count":33,"title":["Ranibizumab monotherapy for sub-foveal haemorrhage secondary to choroidal neovascularisation in age-related macular degeneration"],"prefix":"10.1038","volume":"24","author":[{"given":"M","family":"McKibbin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Papastefanou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Downey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,11,13]]},"reference":[{"key":"BFeye2009271_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1097\/00006982-199616030-00001","volume":"16","author":"R Avery","year":"1996","unstructured":"Avery R, Fekrat S, Hawkins B, Bressler N . Natural history of subretinal subfoveal haemorrhage in age-related macular degeneration. Retina 1996; 16: 183\u2013189.","journal-title":"Retina"},{"issue":"11","key":"BFeye2009271_CR2","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/j.ophtha.2004.07.023","volume":"111","author":"NM Bressler","year":"2004","unstructured":"Bressler NM, Bressler SB, Childs AL, Haller JA, Hawkins BS, Lewis H, et al., Submacular Surgery Trials (SST) Research Group. Surgery for hemorrhagic choroidal neovascular lesions of age-related macular degeneration: ophthalmic findings: SST report no. 13. Ophthalmology 2004; 111 (11): 1993\u20132006.","journal-title":"Ophthalmology"},{"issue":"6","key":"BFeye2009271_CR3","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.ophtha.2003.10.020","volume":"111","author":"S Olivier","year":"2004","unstructured":"Olivier S, Chow DR, Packo KH, MacCumber MW, Awh CC . Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in age-related macular degeneration. Ophthalmology 2004; 111 (6): 1201\u20131208.","journal-title":"Ophthalmology"},{"issue":"3","key":"BFeye2009271_CR4","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/01.iae.0000231544.43093.40","volume":"27","author":"M Gopalakrishan","year":"2007","unstructured":"Gopalakrishan M, Giridhar A, Bhat S, Saikumar SJ, Elias A, N S . Pneumatic displacement of submacular hemorrhage: safety, efficacy, and patient selection. Retina 2007; 27 (3): 329\u2013334.","journal-title":"Retina"},{"issue":"4","key":"BFeye2009271_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/bjo.2005.085001","volume":"90","author":"RP Singh","year":"2006","unstructured":"Singh RP, Patel C, Sears JE . Management of subretinal macular haemorrhage by direct administration of tissue plasminogen activator. Br J Ophthalmol 2006; 90 (4): 429\u2013431.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"BFeye2009271_CR6","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1038\/eye.2008.267","volume":"23","author":"S Sacu","year":"2009","unstructured":"Sacu S, Stifter E, V\u00e9csei-Marlovits PV, Michels S, Sch\u00fctze C, Pr\u00fcnte C et al. Management of extensive subfoveal haemorrhage secondary to neovascular age-related macular degeneration. Eye 2009; 23 (6): 1404\u20131410.","journal-title":"Eye"},{"issue":"6","key":"BFeye2009271_CR7","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.ajo.2007.07.034","volume":"144","author":"E Stifter","year":"2007","unstructured":"Stifter E, Michels S, Prager F, Georgopoulos M, Polak K, Hirn C et al. Intravitreal bevacizumab therapy for neovascular age-related macular degeneration with large submacular hemorrhage. Am J Ophthalmol 2007; 144 (6): 886\u2013892.","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"BFeye2009271_CR8","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1600-0420.2007.01125.x","volume":"86","author":"CH Meyer","year":"2008","unstructured":"Meyer CH, Scholl HP, Eter N, Helb HM, Holz FG . Combined treatment of acute subretinal haemorrhages with intravitreal recombined tissue plasminogen activator, expansile gas and bevacizumab: a retrospective pilot study. Acta Ophthalmol 2008; 86 (5): 490\u2013494.","journal-title":"Acta Ophthalmol"},{"issue":"14","key":"BFeye2009271_CR9","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","volume":"355","author":"PJ Rosenfeld","year":"2006","unstructured":"Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, et al., MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355 (14): 1419\u20131431.","journal-title":"N Engl J Med"},{"issue":"4","key":"BFeye2009271_CR10","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.ajo.2007.01.028","volume":"143","author":"AE Fung","year":"2007","unstructured":"Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007; 143 (4): 566\u2013583.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"BFeye2009271_CR11","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0161-6420(01)00648-0","volume":"108","author":"LO Hattenbach","year":"2001","unstructured":"Hattenbach LO, Klais C, Koch FH, G\u00fcmbel HO . Intravitreous injection of tissue plasminogen activator and gas in the treatment of submacular hemorrhage under various conditions. Ophthalmology 2001; 108 (8): 1485\u20131492.","journal-title":"Ophthalmology"},{"issue":"9","key":"BFeye2009271_CR12","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1007\/s00417-002-0516-5","volume":"240","author":"SD Schulze","year":"2002","unstructured":"Schulze SD, Hesse L . Tissue plasminogen activator plus gas injection in patients with subretinal hemorrhage caused by age-related macular degeneration: predictive variables for visual outcome. Graefes Arch Clin Exp Ophthalmol 2002; 240 (9): 717\u2013720.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye2009271_CR13","unstructured":"Holz FG, Meyer C, Eter N . Safety and efficacy of ranibizumab treatment in patients with neovascular age-related macular degeneration: 12-month results of the SUSTAIN study. Invest Ophthalmol Vis Sci 2009; 50; E-Abstract 3095."},{"issue":"5","key":"BFeye2009271_CR14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1097\/IAE.0b013e3180cc2612","volume":"27","author":"CK Chan","year":"2007","unstructured":"Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT et al. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration. Retina 2007; 27 (5): 541\u2013551.","journal-title":"Retina"},{"issue":"2","key":"BFeye2009271_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1136\/bjo.2007.127902","volume":"92","author":"SV Goverdhan","year":"2008","unstructured":"Goverdhan SV, Lochhead J . Submacular haemorrhages after intravitreal bevacizumab for large occult choroidal neovascularisation in age-related macular degeneration. Br J Ophthalmol 2008; 92 (2): 210\u2013212.","journal-title":"Br J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2009271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2009271","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2009271.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:09:26Z","timestamp":1684429766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2009271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,13]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["BFeye2009271"],"URL":"https:\/\/doi.org\/10.1038\/eye.2009.271","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,13]]}}}